Search for: "SANOFI-PHARMACEUTICALS, INC." Results 81 - 100 of 216
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Apr 2014, 8:50 am by Lawrence B. Ebert
Sanofi-Aventis, Annual Report (Form 20-F), at 61 (Mar. 7, 2008); Teva Pharmaceutical Industries Ltd., Annual Report (Form 20-F), at 20 (Mar. 31, 2001). [read post]
13 Apr 2014, 8:59 am by Barry Sookman
Sanofi-Synthelabo Canada Inc., [2008] 3 SCR 265 At the outset, it is appropriate to refer to the words of Judson J. for this Court in Commissioner of Patents v. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
16 Feb 2014, 4:00 am by Administrator
” LEAVES TO APPEAL GRANTED Pharmaceuticals: Utility; Obviousness Is the patent valid here.Apotex Inc., et al. v. [read post]
12 Dec 2013, 7:12 am
 In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
3 Jan 2013, 4:00 am by Alan Macek
Justice Snider has written in Sanofi-Aventis Canada Inc v Novopharm Ltd, 2009 FC 1139: A review of recent jurisprudence on the issue of awards in intellectual property trials indicates that this scale recognizes the significance and complexity of the various issues in such a trial. [read post]
7 Sep 2012, 3:23 pm by Bexis
Allergan USA, Inc., 2012 WL 3692396 (E.D. [read post]
14 Jun 2012, 11:55 am by Stephen Jenei
That’s $3 billion ahead of its closest competitors, Pfizer and Sanofi. [read post]
10 May 2012, 7:45 am
  A Sanofi Aventis scientist has been sentenced to 18 months in prison for stealing the pharmaceutical company's trade secrets and putting them up for sale through the U.S. branch of a Chinese chemicals company. [read post]
28 Dec 2011, 4:46 pm
San Diego - Genentech filed suit against Regeneron Pharmaceuticals and Sanofi Inc. on December 23, 2011 in the United States District Court, Southern District of New York. [read post]
2 Dec 2011, 2:00 pm by Bexis
Qualitest Pharmaceuticals Inc., 2011 WL 334671, at *3 (E.D. [read post]
9 Nov 2011, 9:59 pm by Patent Docs
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative… [read post]
10 Aug 2011, 4:30 am by Marie Louise
(Patent Docs) Prezista (Darunavir) – US: Patent infringement complaint filed following a Paragraph IV certification: Tibotec Inc. et al. v. [read post]
3 Aug 2011, 3:31 am by Marie Louise
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs)   Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin – US: CAFC… [read post]